Eucontra
Contraception
FiledActive
Key Facts
About Hera Health Solutions
Hera Health Solutions is a private, pre-revenue biotech firm developing a tunable nanofiber-based drug delivery platform capable of sustained release from days to years. The company is advancing a pipeline of long-acting subcutaneous implants and patches, primarily in women's health and substance use disorder, through internal programs and co-development/licensing partnerships. Its strategy is to collaborate with pharmaceutical companies to reformulate existing APIs, leveraging FDA/GMP-approved materials and manufacturing for a potentially streamlined regulatory path.
View full company profileTherapeutic Areas
Other Contraception Drugs
| Drug | Company | Phase |
|---|---|---|
| Drosperinone + Ethinyl Estradiol Tablets | BDR Pharmaceuticals | Commercial |
| Gen II FemCap Commercialization | FemCap | Approved |
| 3Daughters IUD | 3Daughters | Pre-clinical |
| Twirla® (levonorgestrel/ethinyl estradiol) | Agile Therapeutics | Approved |
| Copper 175 mm² IUD | Sebela Pharmaceuticals | Phase 3 |
| SiRx‑Contraception | SiCare Bio | Discovery |
| Novel Oral Contraceptive Combinations | RPG Life Sciences | Formulation Development |
| AYA™ (etonogestrel) contraceptive vaginal system | Organon | Filed |